trial

A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis

NCTId NCT00722163
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Unknown
Enrollment 330 (estimated)
Sponsored by Ontario Mental Health Foundation
Primary completion 2009-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Unknown
Enrollment
330 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
Single
Start
2007-09
Primary completion
2009-05
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
cognitive behavioural therapyBefriending

Sponsors

Ontario Mental Health FoundationLead Sponsor
Schizophrenia Society of OntarioCollaborator

Investigators

1
Jean Addington, PhDPrincipal Investigator

Sites

1 total
Toronto, Canada

Facts & assertions

4 sourced
Enrollment
330
Phase
EARLY_PHASE1
Primary Completion Date
2009-05
Status
UNKNOWN
relationships
The graph out of here
drug
cognitive behavioural therapy
drug
Befriending
drug
lead_sponsor
Ontario Mental Health Foundation
company
collaborator
Schizophrenia Society of Ontario
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Jean Addington, PhD
person